Broken redirects
Jump to navigation
Jump to search
The following redirects link to non-existent pages:
Showing below up to 50 results in range #1,241 to #1,290.
- Salk vaccine → Jonas Salk
- J.W. Gibbs → Josiah Willard Gibbs
- Julius Cohnheim → Julius Friedrich Cohnheim
- Jons Jakob Berzelius → Jöns Jakob Berzelius
- Kaj Ulrik Linderstrom-Lang → Kaj Ulrik Linderstrøm-Lang
- Karolinska Institute → Karolinska Institutet
- P-32 → Kel-Tec P-32
- Shibasaburo Kitasato → Kitasato Shibasaburo
- Kosher → Kosher foods
- KAT II → Kuopio Angiogenesis Trial
- Azure → Lapis lazuli
- Laplace’s Law → Laplace’s law
- LACI → Laser Angioplasty For Critical Ischemia
- LATE → Late Assessment Of Thrombolytic Efficacy Study
- BASKET LATE → Late Clinical Events Related To Late Stent Thrombosis After Stopping Clopidogrel
- LASMA → Late aquired stent malapposition
- Lateral cutaneous branches of torso → Lateral abdominal cutaneous branch of intercostal nerve
- Leopold Ruzicka → Lavoslav Ružička
- Lazar Edeleanu → Lazăr Edeleanu
- Guardianship → Legal guardian
- Guardian ad litem → Legal guardian
- Lehmann-Scheffé theorem → Lehmann–Scheffé theorem
- Lemon oil → Lemon
- Lemon Balm → Lemon balm
- LISA → Lescol In Severe Atherosclerosis Trial
- LIPS → Lescol Intervention Prevention Study
- LIDO → Levosimendan Infusion Versus Dobutamine
- Jaffe-Lichtenstein-Sutro syndrome → Lichtenstein syndrome
- LHT → Lifestyle Heart Trial
- Light-chain nephropathy → Light chain disease
- Light source → Light sources
- LIMB → Limbs International Medical Buflomedil Trial
- LIMIT AMI → Limitation Of Myocardial Infarction Following Thrombolysis In Acute
- LEADERS → Limus Eluted From A Durable Vs Erodable Stent Coating
- Lips → Lip (disambiguation)
- L-CAD → Lipid-Coronary Artery Disease (Pravastatin)
- SLIP → Lipid Profile During Antihypertensive Treatment
- LRC-CPPT → Lipid Research Clinics Coronary Primary Prevention Trial
- Ddx:Lipoprotein (a) → Lipoprotein (a)
- Hyperlipidemia case study one → Lipoprotein disorders case study one
- Hyperlipidemia cost-effectiveness of therapy → Lipoprotein disorders cost-effectiveness of therapy
- Hyperlipidemia differential diagnosis → Lipoprotein disorders differential diagnosis
- Hyperlipidemia epidemiology and demographics → Lipoprotein disorders epidemiology and demographics
- Hyperlipidemia future or investigational therapies → Lipoprotein disorders future or investigational therapies
- Hyperlipidemia history and symptoms → Lipoprotein disorders history and symptoms
- Hyperlipidemia laboratory findings → Lipoprotein disorders laboratory findings
- Hyperlipidemia medical therapy → Lipoprotein disorders medical therapy
- Hyperlipidemia natural history, complications and prognosis → Lipoprotein disorders natural history, complications and prognosis
- Hyperlipidemia pathophysiology → Lipoprotein disorders pathophysiology
- Genetics of lipoprotein disorders → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders